LifeStance Health Group (NASDAQ:LFST) Reaches New 1-Year Low - Here's Why

Key Points

• LifeStance Health Group's stock (NASDAQ:LFST) hit a new **52-week low** at $4.09 on Tuesday, down from a prior closing price of $4.17.
• Analysts remain positive, with ratings such as "**buy**" from Canaccord Genuity and UBS Group, and a consensus price target of **$8.42**.
• Insider **Ujjwal Ramtekkar** sold 16,000 shares, indicating a **12.36% reduction** in their stake, while institutional investors hold **85.50%** of the company’s stock.

LifeStance Health Group, Inc. (NASDAQ:LFST - Get Free Report) reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $4.09 and last traded at $4.11, with a volume of 575174 shares changing hands. The stock had previously closed at $4.17.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target for the company in a report on Tuesday, May 27th. BTIG Research initiated coverage on shares of LifeStance Health Group in a research report on Friday, July 25th. They set a "buy" rating and a $8.00 price target on the stock. Canaccord Genuity Group initiated coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target on the stock. Finally, KeyCorp initiated coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They set an "overweight" rating and a $9.00 price target on the stock. One equities research analyst has rated the stock with a sell rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $8.42.

LifeStance Health Group Price Performance

The company has a debt-to-equity ratio of 0.19, a current ratio of 1.47 and a quick ratio of 1.47. The stock has a market cap of $1.48 billion, a price-to-earnings ratio of -38.05 and a beta of 1.16. The business's 50-day simple moving average is $5.00 and its two-hundred day simple moving average is $6.36.

Insiders Place Their Bets

In other LifeStance Health Group news, insider Ujjwal Ramtekkar sold 16,000 shares of the firm's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $5.94, for a total value of $95,040.00. Following the sale, the insider owned 113,435 shares in the company, valued at $673,803.90. This trade represents a 12.36% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 3.20% of the stock is owned by corporate insiders.

Institutional Trading of LifeStance Health Group

A number of hedge funds have recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its position in LifeStance Health Group by 5.0% in the first quarter. Vanguard Group Inc. now owns 11,221,237 shares of the company's stock valued at $74,733,000 after buying an additional 531,841 shares in the last quarter. Jennison Associates LLC lifted its holdings in shares of LifeStance Health Group by 2.1% during the first quarter. Jennison Associates LLC now owns 8,255,236 shares of the company's stock worth $54,980,000 after purchasing an additional 168,856 shares during the period. Wellington Management Group LLP lifted its holdings in shares of LifeStance Health Group by 2.3% during the first quarter. Wellington Management Group LLP now owns 5,399,293 shares of the company's stock worth $35,959,000 after purchasing an additional 123,056 shares during the period. Dimensional Fund Advisors LP lifted its holdings in shares of LifeStance Health Group by 87.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,524,529 shares of the company's stock worth $25,977,000 after purchasing an additional 1,643,390 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in shares of LifeStance Health Group by 0.4% during the fourth quarter. Geode Capital Management LLC now owns 3,465,471 shares of the company's stock worth $25,546,000 after purchasing an additional 13,293 shares during the period. Institutional investors and hedge funds own 85.50% of the company's stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.